{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T19:32:18Z","timestamp":1697398338557},"reference-count":40,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.ejphar.2003.11.023","type":"journal-article","created":{"date-parts":[[2003,12,16]],"date-time":"2003-12-16T10:59:24Z","timestamp":1071572364000},"page":"209-215","source":"Crossref","is-referenced-by-count":7,"title":["Sibutramine induces potential-dependent exocytotic release but not carrier-mediated release of dopamine and 5-hydroxytryptamine"],"prefix":"10.1016","volume":"484","author":[{"given":"Kiyoharu","family":"Ukai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terutake","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2003.11.023_BIB1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00165384","article-title":"The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons","volume":"347","author":"Arborelius","year":"1993","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1476-5381.1996.tb15749.x","article-title":"Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats","volume":"119","author":"Assie","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB3","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/S0028-3908(00)00083-6","article-title":"Sibutramine, a serotonin uptake inhibitor, increases dopamine concentrations in rat striatal and hypothalamic extracellular fluid","volume":"39","author":"Balcioglu","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2003.11.023_BIB4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/j.1550-8528.1996.tb00544.x","article-title":"A double blind randomized placebo-controlled trial of sibutramine","volume":"4","author":"Bray","year":"1996","journal-title":"Obes. Res."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1471-4159.1988.tb02919.x","article-title":"Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study","volume":"50","author":"Butcher","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB6","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1523\/JNEUROSCI.18-07-02729.1998","article-title":"Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of d-amphetamine","volume":"18","author":"Darracq","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB7","first-page":"9","article-title":"Regulation of extracellular concentrations of norepinephrine in hypothalamus of the conscious rat: effect of amitriptyline","volume":"39","author":"Engleman","year":"1996","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB8","series-title":"Review of Medical Physiology","first-page":"221","author":"Ganong","year":"1999"},{"key":"10.1016\/j.ejphar.2003.11.023_BIB9","first-page":"581","article-title":"In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor","volume":"283","author":"Gundlah","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF02245152","article-title":"A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine","volume":"107","author":"Heal","year":"1992","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2003.11.023_BIB11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-2999(95)00624-9","article-title":"R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens","volume":"287","author":"Ichikawa","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0091-3057(94)00275-N","article-title":"D2 receptors in the ventrolateral striatum are involved in feeding behavior in rats","volume":"50","author":"Inoue","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB13","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/sj.bjp.0701311","article-title":"Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat","volume":"121","author":"Jackson","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB14","first-page":"133","article-title":"Serotonin 5-HT1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum","volume":"266","author":"Johnson","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/syn.890180404","article-title":"In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine","volume":"18","author":"Jordan","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2003.11.023_BIB16","first-page":"1268","article-title":"Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei","volume":"269","author":"Kreiss","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB17","article-title":"Down-regulation of rat cortical \u03b2 adrenoceptors by the putative antidepressant BTS 54 524: contribution of metabolites","volume":"92","author":"Luscombe","year":"1987","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(96)00315-9","article-title":"Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens","volume":"309","author":"Mathe","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(99)00636-6","article-title":"Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex","volume":"383","author":"Matsumoto","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2165\/00003495-199856060-00019","article-title":"Sibutramine (A review of its contribution to the management of obesity)","volume":"56","author":"McNeely","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2003.11.023_BIB22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0361-9230(95)92128-3","article-title":"Eating induced rise in LHA-dopamine correlates with meal size in normal and bulbectomized rats","volume":"36","author":"Meguid","year":"1995","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB23","first-page":"90","article-title":"Pharmacokinetic and pharmacodynamic analysis of the actions of d-amphetamine and d-methamphetamine on the dopamine terminal","volume":"274","author":"Melega","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/oby.2003.85","article-title":"Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm","volume":"11","author":"Mitchell","year":"2003","journal-title":"Obes. Res."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB25","first-page":"11","article-title":"Antidepressive effects of the stereoisomer cis-dosulepin hydrochloride","volume":"43","author":"Nakagawa","year":"1993","journal-title":"Arzneimittel-Forschung"},{"key":"10.1016\/j.ejphar.2003.11.023_BIB26","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0091-3057(97)98984-X","article-title":"Effects of dopaminergic agents on reversal of reserpine-induced impairment in conditioned avoidance response in rats","volume":"58","author":"Nakagawa","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB27","first-page":"71","article-title":"Effect of dopaminergic drugs on reserpine-induced lowering of hippocampal theta-wave frequency in rats","volume":"20","author":"Nakagawa","year":"2000","journal-title":"Jpn. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1538\/expanim.49.239","article-title":"Effects of chronic administration of sibutramine on body weight, food in take and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamine","volume":"49","author":"Nakagawa","year":"2000","journal-title":"Exp. Anim."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF03033262","article-title":"Effects of sibutramine on the central dopaminergic system in rodents","volume":"3","author":"Nakagawa","year":"2001","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB32","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.ejphar.2003.11.023_BIB33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0014-2999(94)90300-X","article-title":"Alpha 1-adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: a microdialysis study","volume":"261","author":"Rouquier","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0773.1993.tb01537.x","article-title":"Neurochemical mechanism of action of anorectic drugs","volume":"73","author":"Samanin","year":"1993","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/(SICI)1097-4547(19980601)52:5<591::AID-JNR11>3.0.CO;2-5","article-title":"Influence of serotoninergic drugs on in vivo dopamine extracellular output in rat striatum","volume":"52","author":"Santiago","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02244785","article-title":"Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?","volume":"115","author":"Tanda","year":"1994","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2003.11.023_BIB37","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/BF00169306","article-title":"The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis","volume":"336","author":"Westerink","year":"1987","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB38","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1471-4159.1989.tb02514.x","article-title":"Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis","volume":"52","author":"Westerink","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB39","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/00001756-199505300-00029","article-title":"LHA dopaminergic activity in obese and lean Zucker rats","volume":"6","author":"Yang","year":"1995","journal-title":"NeuroReport"},{"key":"10.1016\/j.ejphar.2003.11.023_BIB40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0091-3057(97)00022-1","article-title":"Bilateral hypothalamic dopamine perfusion in male Zucker rat suppresses feeding due to reduced meal size","volume":"58","author":"Yang","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB41","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/00001756-199704140-00044","article-title":"Eating-associated VMN-dopamine levels of rats: comparison of oral and intragastric feeding","volume":"8","author":"Yang","year":"1997","journal-title":"NeuroReport"},{"key":"10.1016\/j.ejphar.2003.11.023_BIB42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1471-4159.1990.tb13301.x","article-title":"Intrasynaptosomal sequestration of [3H]amphetamine and [3H]methylendioxyaphetamine: characterization suggests the presence of a factor responsible for maintaining sequestration","volume":"54","author":"Zaczek","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2003.11.023_BIB43","first-page":"820","article-title":"Interactions of [3H]amphetamine with rat brain synptosomes: I. Saturable sequestration","volume":"257","author":"Zaczek","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299903026670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299903026670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T03:57:17Z","timestamp":1585367837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299903026670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":40,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0014299903026670"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2003.11.023","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}